Advil Maker Haleon Said to Study Potential Deals to Bulk Up (1)

Haleon Plc, the consumer health business spun out from British pharmaceutical producer GSK Plc, is in the early stages of studying large potential deals to bulk up its brand portfolio, people with knowledge of the matter said.

London-listed Haleon has been evaluating the merits of possible transactions for the medium- to long-term, including a combination with Sanofi’s $30 billion consumer-health arm, according to the people.

Haleon shares rose as much as 4.3% on Tuesday. The stock was up 1.1% at 2:17 p.m. in London, giving the company a market value of £29.9 billion ($36.9 billion).

Haleon, ...